The Biology of BLS-I and How It Is Diagnosed

To understand Bare Lymphocyte Syndrome Type I (BLS-I), it helps to think of your cells as high-security buildings. Every building (cell) must display a specific “ID badge” on its outer wall to tell the immune system it belongs there and isn’t hiding a virus ^[1]. In BLS-I, a breakdown in the assembly line means these ID badges—known as Major Histocompatibility Complex (MHC) Class I molecules—never make it to the surface ^[2].

The Assembly Line Failure

Inside your cells, there is a specialized machine called the peptide-loading complex ^[1]. Its job is to take small pieces of protein (peptides) from the center of the cell and “load” them onto the MHC Class I ID badge ^[3].

When the genes that build this machine are mutated, the system fails:

• TAP1 and TAP2 Mutations: These genes build the “bridge” (the TAP transporter) that moves peptides into the loading area. If the bridge is broken, there are no peptides to load ^[4][5].
• TAPBP (Tapasin) Mutation: This gene acts like a quality-control manager. It helps the ID badge find the right peptide and stay stable. Without it, the ID badges may get stuck inside the cell or fall apart before they reach the surface ^[2].
• B2M Mutation: This gene provides a critical structural piece of the ID badge itself. Without it, the badge cannot be built at all ^[6].

Because the “badges” are trapped inside or never built, the immune system’s primary “security guards” (CD8+ T cells) cannot see what the cells are doing, which allows certain infections to take hold ^[2].

Diagnostic Testing: What the Labs Show

Diagnosing BLS-I requires specialized blood tests because standard immune panels can be misleadingly normal.

1. Flow Cytometry (The “Badge” Check)

The most important screen is flow cytometry for HLA-ABC ^[7]. This test estimates the relative expression of these MHC Class I molecules on the surface of your white blood cells.

• In BLS-I, the surface expression of these molecules is typically very low—sometimes between 0% and 15% depending on the specific gene and residual function ^[4].
• Doctors look at the Mean Fluorescence Intensity (MFI) compared to appropriate healthy controls, which measures how “brightly” the badges shine. In BLS-I, this brightness is very dim ^[7].

2. The CD8+ T Cell Trap

A common mistake is assuming a “normal” T cell count means the immune system is fine. In BLS-I:

• Total CD8+ counts can look completely normal in about half of all patients ^[8].
• Naïve CD8+ T cells (the “rookie” cells that haven’t fought an infection yet) are usually very low ^[4].
• Gamma-delta (γδ) T cells are often significantly expanded or increased ^[7]. While not unique to BLS-I, this is a supportive finding that can tip off a savvy immunologist.

3. Genetic Confirmation

The final confirmation for diagnosis is genetic testing. A complete report should confirm biallelic mutations, meaning one mutation was inherited from the mother and one from the father (or a homozygous mutation is present). A full evaluation often requires parental phase testing and genetics counseling ^[8]. The report should list the specific gene involved (TAP1, TAP2, TAPBP, or B2M) and the exact location of the error using HGVS nomenclature (for example, a code like c.312del) ^[2].

Knowing your specific mutation is helpful because it tells your care team exactly which part of the “assembly line” is broken ^[6][4]. If the lab reports a variant of uncertain significance, functional confirmation tests can check how well the TAP transporter actually works.